Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Molecular Microbiology|June 1, 1994
Identification of a novel sugar-H+ symport protein, FucP, for transport of L-fucose into Escherichia coliF J Gunn, C G Tate, P J Henderson
The EMBO Journal|February 28, 2001
The projection structure of EmrE, a proton-linked multidrug transporter from Escherichia coli, at 7 A resolutionC G Tate, E R Kunji, M Lebendiker, et al.
Molecular Pharmacology|August 1, 1996
Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognitionH E Melikian, S Ramamoorthy, C G Tate, et al.
Journal of Molecular Biology|June 30, 2004
The Escherichia coli multidrug transporter EmrE is a dimer in the detergent-solubilised stateP J G Butler, I Ubarretxena-Belandia, T Warne, et al.
The Biochemical Journal|November 1, 1989
Studies on human red-cell membrane glycophorin A and glycophorin B genes in glycophorin-deficient individualsC G Tate, M J Tanner, P A Judson, et al.
Molecular Microbiology|February 1, 1995
Topological analyses of the L-fucose-H+ symport protein, FucP, from Escherichia coliF J Gunn, C G Tate, C E Sansom, et al.
The Journal of Biological Chemistry|November 4, 2000
Biophysical characterization of the cocaine binding pocket in the serotonin transporter using a fluorescent cocaine analogue as a molecular reporterS G Rasmussen, F I Carroll, M J Maresch, et al.
News in Physiological Sciences : an International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society|July 10, 2001
Small is mighty: EmrE, a multidrug transporter as an experimental paradigmS Schuldiner, D Granot, S S Mordoch, et al.
The Biochemical Journal|March 15, 1993
Proton-linked L-rhamnose transport, and its comparison with L-fucose transport in EnterobacteriaceaeJ A Muiry, T C Gunn, T P McDonald, et al.
The Biochemical Journal|July 15, 1989
Studies on the defect which causes absence of decay accelerating factor (DAF) from the peripheral blood cells of an individual with the Inab phenotypeC G Tate, M Uchikawa, M J Tanner, et al.
Pageof 4